$-0.92 EPS Expected for Achaogen, Inc. (AKAO); Edgemoor Investment Advisors Boosted Priceline Grp (PCLN) Holding

April 17, 2018 - By Neil V. Hobbs

Achaogen, Inc. (NASDAQ:AKAO) Logo

Edgemoor Investment Advisors Inc increased Priceline Grp Inc (PCLN) stake by 6.92% reported in 2017Q4 SEC filing. Edgemoor Investment Advisors Inc acquired 328 shares as Priceline Grp Inc (PCLN)’s stock 0.00%. The Edgemoor Investment Advisors Inc holds 5,070 shares with $9.73M value, up from 4,742 last quarter. Priceline Grp Inc now has $92.94 billion valuation. The stock decreased 0.07% or $1.38 during the last trading session, reaching $1905.64. About 570,074 shares traded or 35.79% up from the average. Booking Holdings Inc. (NASDAQ:PCLN) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect Achaogen, Inc. (NASDAQ:AKAO) to report $-0.92 EPS on May, 14.They anticipate $0.41 EPS change or 80.39% from last quarter’s $-0.51 EPS. After having $-0.98 EPS previously, Achaogen, Inc.’s analysts see -6.12% EPS growth. The stock increased 1.47% or $0.18 during the last trading session, reaching $12.39. About 705,287 shares traded. Achaogen, Inc. (NASDAQ:AKAO) has declined 41.74% since April 17, 2017 and is downtrending. It has underperformed by 53.29% the S&P500.

Among 10 analysts covering Achaogen (NASDAQ:AKAO), 9 have Buy rating, 1 Sell and 0 Hold. Therefore 90% are positive. Achaogen had 25 analyst reports since March 16, 2016 according to SRatingsIntel. Cowen & Co maintained the stock with “Buy” rating in Thursday, June 1 report. The stock of Achaogen, Inc. (NASDAQ:AKAO) has “Buy” rating given on Wednesday, February 28 by Mizuho. Wedbush maintained the shares of AKAO in report on Wednesday, February 1 with “Outperform” rating. Leerink Swann maintained the stock with “Outperform” rating in Monday, October 9 report. Leerink Swann initiated Achaogen, Inc. (NASDAQ:AKAO) on Wednesday, January 4 with “Outperform” rating. On Wednesday, March 16 the stock rating was downgraded by Needham to “Hold”. The rating was maintained by Cowen & Co on Tuesday, January 2 with “Buy”. Needham maintained Achaogen, Inc. (NASDAQ:AKAO) rating on Friday, September 15. Needham has “Buy” rating and $29.0 target. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, August 3. Needham maintained Achaogen, Inc. (NASDAQ:AKAO) on Wednesday, February 28 with “Buy” rating.

Since December 18, 2017, it had 9 buys, and 5 insider sales for $10.50 million activity. The insider DUGGAN ROBERT W bought 527,396 shares worth $5.44 million. Hillan Kenneth J. also sold $49,146 worth of Achaogen, Inc. (NASDAQ:AKAO) shares. Shares for $11,822 were sold by Schilke Tobin. Swem Lee also sold $13,679 worth of Achaogen, Inc. (NASDAQ:AKAO) shares. 1,640 shares valued at $17,499 were sold by Wise Blake on Wednesday, February 21.

Investors sentiment increased to 1.32 in 2017 Q4. Its up 0.16, from 1.16 in 2017Q3. It improved, as 16 investors sold Achaogen, Inc. shares while 21 reduced holdings. 22 funds opened positions while 27 raised stakes. 29.75 million shares or 6.36% less from 31.77 million shares in 2017Q3 were reported. Price T Rowe Assoc Md invested in 0% or 947,056 shares. First Midwest Comml Bank Trust Division stated it has 374,007 shares or 0.5% of all its holdings. Wells Fargo Mn has 50,683 shares for 0% of their portfolio. State Street invested in 0% or 2.38M shares. Dsc Lp has invested 0.44% of its portfolio in Achaogen, Inc. (NASDAQ:AKAO). Morgan Stanley reported 0% stake. Barclays Plc invested 0% of its portfolio in Achaogen, Inc. (NASDAQ:AKAO). Contravisory Invest Mgmt Inc holds 0% or 27 shares in its portfolio. Us National Bank De owns 6,119 shares or 0% of their US portfolio. Trexquant Invest Lp accumulated 0.06% or 47,742 shares. Citigroup owns 92,949 shares or 0% of their US portfolio. Tiaa Cref Inv Management Limited Co has 0% invested in Achaogen, Inc. (NASDAQ:AKAO). Hikari Limited owns 0.08% invested in Achaogen, Inc. (NASDAQ:AKAO) for 60,000 shares. Fmr Limited Liability has invested 0.01% in Achaogen, Inc. (NASDAQ:AKAO). Clear Harbor Asset Llc owns 16,511 shares for 0.03% of their portfolio.

Achaogen, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant gram-negative infections in the United States. The company has market cap of $554.15 million. The firm is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections, including urinary tract infections, blood stream infections, and other infections due to MDR Enterobacteriaceae comprising carbapenem-resistant Enterobacteriaceae. It currently has negative earnings. It is also involved in the research and development of antipseudomonal LpxC inhibitor compounds for the treatment of bacterial infections; and therapeutic antibody discovery program.

Among 34 analysts covering Priceline.com (NASDAQ:PCLN), 26 have Buy rating, 0 Sell and 8 Hold. Therefore 76% are positive. Priceline.com had 101 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, November 7. The firm earned “Hold” rating on Thursday, August 6 by Deutsche Bank. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, August 5. The rating was maintained by Deutsche Bank with “Hold” on Wednesday, August 9. The rating was maintained by RBC Capital Markets on Thursday, November 2 with “Buy”. The firm has “Hold” rating given on Tuesday, July 25 by Wells Fargo. The company was maintained on Tuesday, November 7 by Credit Suisse. Jefferies maintained the stock with “Buy” rating in Wednesday, June 21 report. The rating was maintained by Needham with “Buy” on Tuesday, November 7. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, October 7 report.

Edgemoor Investment Advisors Inc decreased 3M Co (NYSE:MMM) stake by 2,394 shares to 87,559 valued at $21.43M in 2017Q4. It also reduced Pnc Finl Svcs Group Inc (NYSE:PNC) stake by 7,532 shares and now owns 154,735 shares. Eastman Chem Co (NYSE:EMN) was reduced too.

Achaogen, Inc. (NASDAQ:AKAO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: